Vanguard Group Inc Kal Vista Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,150,527 shares of KALV stock, worth $20 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,150,527

Previous 1,990,588 8.03%

Holding current value

$20 Million

Previous $23.4 Million 6.2%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$9.46 - $15.39 $1.51 Million - $2.46 Million	159,939 Added 8.03%	2,150,527 $24.9 Million
Q2 2024 Aug 13, 2024	BUY	$10.35 - $12.49 $3.16 Million - $3.82 Million	305,475 Added 18.13%	1,990,588 $23.4 Million
Q1 2024 May 10, 2024	SELL	$11.07 - $16.04 $1.07 Million - $1.54 Million	-96,306 Reduced 5.41%	1,685,113 $20 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $370,889 - $599,392	48,930 Added 2.82%	1,781,419 $21.8 Million
Q3 2023 Nov 14, 2023	BUY	$8.95 - $11.35 $1.36 Million - $1.72 Million	151,808 Added 9.6%	1,732,489 $16.7 Million
Q2 2023 Aug 14, 2023	SELL	$7.73 - $10.57 $14,261 - $19,501	-1,845 Reduced 0.12%	1,580,681 $14.2 Million
Q1 2023 May 15, 2023	BUY	$6.3 - $8.39 $2.71 Million - $3.61 Million	429,853 Added 37.29%	1,582,526 $12.4 Million
Q4 2022 Feb 10, 2023	BUY	$4.2 - $14.24 $11,810 - $40,042	2,812 Added 0.24%	1,152,673 $7.79 Million
Q3 2022 Nov 14, 2022	SELL	$9.85 - $16.83 $71,875 - $122,808	-7,297 Reduced 0.63%	1,149,861 $16.7 Million
Q2 2022 Aug 12, 2022	SELL	$8.16 - $15.1 $77,471 - $143,359	-9,494 Reduced 0.81%	1,157,158 $11.4 Million
Q1 2022 May 13, 2022	BUY	$11.2 - $16.97 $315,481 - $478,010	28,168 Added 2.47%	1,166,652 $17.2 Million
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $596,530 - $882,247	-48,263 Reduced 4.07%	1,138,484 $15.1 Million
Q3 2021 Nov 12, 2021	BUY	$17.11 - $24.49 $3.8 Million - $5.44 Million	222,328 Added 23.05%	1,186,747 $20.7 Million
Q2 2021 Aug 13, 2021	BUY	$23.12 - $29.91 $22.3 Million - $28.8 Million	964,419 New	964,419 $23.1 Million

Others Institutions Holding KALV

# of Institutions

125

Shares Held

47.8M

Call Options Held

551K

Put Options Held

110K

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $229M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Kal Vista Pharmaceuticals, Inc. Transaction History